Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

600276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd.

Closed 06-05 15:00:00

47.08

+0.45

+0.97%

High48.72	Low47.00	Vol93.03M
Open47.48	D1 Closing46.63	Amplitude3.69%
Mkt Cap312.47B	Tradable Cap300.32B	Total Shares6.64B
T/O4.45B	T/O Rate1.46%	Tradable Shares6.38B
P/B4.91	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":47.08,"timestamp":1780642800000,"preClose":46.63,"halted":0,"volume":93026396,"delay":0,"changeRate":0.0097,"floatShares":6379000000,"shares":6637000000,"eps":1.2233,"marketStatus":"Closed","change":0.45,"latestTime":"06-05 15:00:00","open":47.48,"high":48.72,"low":47,"amount":4447000000,"amplitude":0.0369,"askPrice":47.09,"askSize":123,"bidPrice":47.08,"bidSize":994,"shortable":0,"etf":0,"ttmEps":1.2233,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1780882200000},"marketStatusCode":5,"adr":0,"adjPreClose":46.63,"symbolType":"stock","openAndCloseTimeList":[[1780623000000,1780630200000],[1780635600000,1780642800000]],"highLimit":51.29,"lowLimit":41.97,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6637199874,"isCdr":false,"pbRate":4.91,"roa":"--","peRate":38.486062,"roe":"4.15%","epsLYR":1.19,"committee":0.413203,"marketValue":312479000000,"turnoverRate":0.0146,"status":0,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2026-06-08.","hkstockBrief":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":54.5,"timestamp":1780646952002,"preClose":53.35,"halted":0,"volume":5580278,"delay":0,"premium":"+0.19"},"floatMarketCap":300323000000},"requestUrl":"/m/hq/s/600276/tweets","defaultTab":"tweets","newsList":[{"id":"1186929982","title":"Hengrui Pharma Shares Surge on Positive ASCO Presentation for Liver Cancer Treatment Combo","url":"https://stock-news.laohu8.com/highlight/detail?id=1186929982","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186929982?lang=en_us&edition=fundamental","pubTime":"2026-06-05 10:00","pubTimestamp":1780624830,"startTime":"0","endTime":"0","summary":"Shares of Hengrui Pharma (ASX: 01276) rose over 5% in trading. At the time of writing, the stock was up 4.69% to HK$55.85, with a turnover of HK$101 million. The catalyst for the move was news from...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","BK0188","BK1191","BK0060","LU1997244956.HKD","LU1580142542.USD","LU1997245177.USD","LU1064130708.USD","LU1023057109.AUD","LU0359201885.HKD","LU1146622755.USD","LU1997245094.SGD","LU2488822045.USD","BK4588","LU1969619763.USD","LU2097828805.USD","BK0183","LU2543165471.USD","BK0012","LU2097828474.EUR","LU1255011170.USD","LU2580892789.USD","LU0359202008.SGD","VXUS","BK0028","LU0405327148.USD","LU0359201612.USD","LU1655091616.SGD","LU1820825898.SGD","LU1064131003.USD","LU2289578879.USD","LU1781817850.SGD","LU2495084118.USD","LU2097828631.EUR","BK0239","BK0196","LU2097828714.EUR","LU2328871848.SGD","01276","LU1328615791.USD","LU2148510915.USD","BK4585","600276","TACE","LU0405327494.USD","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119703715","title":"Hengrui Pharma Conducts Share Buyback on June 4th","url":"https://stock-news.laohu8.com/highlight/detail?id=1119703715","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119703715?lang=en_us&edition=fundamental","pubTime":"2026-06-04 17:21","pubTimestamp":1780564891,"startTime":"0","endTime":"0","summary":"On June 4th, Hengrui Pharma (01276) executed a share repurchase transaction. The company invested approximately 19.82 million yuan to buy back 420,000 of its own A-shares. The repurchase price per share ranged between 46.7 yuan and 47.7 yuan.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1781817850.SGD","LU2488822045.USD","600276","LU1255011170.USD","BK0028","LU2097828557.USD","BK0196","LU1064131003.USD","LU1580142542.USD","LU0405327148.USD","LU2495084118.USD","LU1328615791.USD","BK1191","LU2097828805.USD","BK0183","399300","LU2328871848.SGD","LU2148510915.USD","LU1655091616.SGD","LU2543165471.USD","LU0405327494.USD","LU1997245094.SGD","LU2097828631.EUR","LU0359202008.SGD","BK0060","LU2097828474.EUR","LU0359201612.USD","BK0012","LU1023057109.AUD","LU1997245177.USD","LU1064130708.USD","BK0188","LU2580892789.USD","159982","LU1146622755.USD","LU1820825898.SGD","01276","LU2580892862.HKD","LU1969619763.USD","LU1997244956.HKD","LU0359201885.HKD","BK0239","LU2097828714.EUR","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640155952","title":"Jiangsu Hengrui files HKEX next-day return disclosing share buyback at RMB 47.2 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2640155952","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640155952?lang=en_us&edition=fundamental","pubTime":"2026-06-04 17:17","pubTimestamp":1780564674,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui repurchased 420,000 A shares on June 4, 2026 for treasury stock.Buyback price range RMB 46.7-47.7 per share; total consideration RMB 19.82 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Hengrui Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL9Kc4WG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2148510915.USD","LU2097828714.EUR","LU1146622755.USD","LU2097828631.EUR","LU2097828474.EUR","BK0028","LU2328871848.SGD","LU2488822045.USD","LU1255011170.USD","LU2580892862.HKD","LU1820825898.SGD","BK0239","LU1655091616.SGD","LU2097828805.USD","BK0196","BK0012","LU2495084118.USD","600276","LU1064131003.USD","LU1969619763.USD","BK0188","LU0405327494.USD","LU2097828557.USD","BK0060","LU0405327148.USD","LU1997245094.SGD","LU1781817850.SGD","LU1580142542.USD","LU1997245177.USD","LU2289578879.USD","LU2580892789.USD","LU1064130708.USD","LU1997244956.HKD","LU1328615791.USD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154068328","title":"Major Tech and Pharma Stocks Decline in Hong Kong Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1154068328","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154068328?lang=en_us&edition=fundamental","pubTime":"2026-06-03 16:54","pubTimestamp":1780476863,"startTime":"0","endTime":"0","summary":"On June 3rd, the Hong Kong Hang Seng Index closed down 1.56%, while the Hang Seng Tech Index fell by 2.74%.Technology and internet stocks were broadly lower. Kingdee International dropped over 7%,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"25f8dd9617211a124d0de22ad23bb88a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423091.SGD","BK4504","BK1610","TCEHY","LU0132412106.USD","HK0001040143.USD","LU2580892789.USD","LU0084288322.USD","LU1880383366.USD","LU0254981946.USD","LU2177674079.SGD","BK4607","LU0106959298.USD","LU2097828805.USD","LU0577902538.SGD","BK1589","MPNGY","LU0259732245.USD","LU1814569148.SGD","LU0196878994.USD","SG9999015952.SGD","LU0029874905.USD","SG9999000327.SGD","LU0823426480.USD","BABW","BK4538","LU1064130708.USD","BK1142","LU0572944931.SGD","SG9999002828.SGD","LU1226288170.HKD","IE0009570106.USD","600276","LU0819123356.HKD","03067","IE00BF5LJ272.USD","LU0499858438.USD","LU0370786039.SGD","SG9999001226.SGD","LU0878005551.USD","LU1642822792.SGD","LU2237443549.SGD","SGXZ31699556.SGD","LU1152091168.USD","BK4587","BK1619","LU0823039010.USD","LU0127658192.USD","LU0128522744.USD","BK4534","SG9999014674.SGD","LU2580892862.HKD","03423","LU0608807433.USD","IE0003795394.USD","IE00BQXX3C00.GBP","LU0264606111.USD","LU0509642566.USD","HK0001040168.HKD","LU1242518931.SGD","BK1502","BK1583","LU0516422366.SGD","BK1575","LU0577902371.SGD","LU1769817096.USD","LU0417516571.SGD","LU0455707207.USD","LU1997244956.HKD","LU0164872284.USD","LU2317271919.USD","LU0882747503.HKD","LU1960683339.HKD","LU0553294199.USD","LU0823397285.USD","LU0918141705.HKD","LU1719994722.HKD","SG9999018857.SGD","BK4505","LU0642271901.SGD","LU1008478684.HKD","LU1102505929.USD","LU1439103000.SGD","LU0261950983.USD","LU2226246903.HKD","IE00B5MMRT66.SGD","BK0028","LU1733274473.HKD","LU0261947096.USD","03037","LU1974910355.USD","03088","07200","LU0049112450.USD","BK4565","LU3063872942.SGD","HHImain","LU0868486357.SGD","LU1226287875.USD","LU0149721374.USD","LU0106259558.USD","LU0594300179.USD","LU0052750758.USD","LU2133065610.SGD","LU1242518857.USD","LU1823568750.SGD","LU0985320562.USD","LU0572940350.SGD","LU1226287792.SGD","HTImain","LU2087589342.USD","09618","LU0061477393.USD","LU2328871848.SGD","LU0328353924.USD","SG9999002463.SGD","LU0345769128.USD","LU0449509016.USD","LU0918141887.USD","00700","02269","JD","LU2106854487.HKD","BK0239","BK1588","IE00BGV7N243.SGD","09988","BK4122","LU1481107354.HKD","07300","LU0229945570.USD","LU0737861699.HKD","513600","LU0414403682.SGD","LU1146622755.USD","LU2237443622.USD","LU1917777945.USD","LU1993786604.SGD","LU0972618739.USD","LU1568876335.HKD","BK1609","BK4535","LU2449936058.SGD","SGXZ81514606.USD","LU0143863784.USD","LU0640798160.USD","IE00BPRC5H50.USD","HTCD.SI","LU0327786744.USD","LU1880383440.USD","LU0633140727.USD","LU2097828557.USD","LU0396098781.USD","LU2148510915.USD","LU1439102457.SGD","03032","BK4558","LU0683595622.HKD","IE0008368742.USD","LU0348735423.USD","LU0593848301.USD","LU1044875133.USD","LU0203345920.USD","LU1328277881.USD","LU0456827905.SGD","02800","LU1675838814.USD","LU0823038988.USD","LU0541502299.USD","LU1969619763.USD","IE00B0169N27.USD","LU0865486749.SGD","SG9999001069.SGD","LU0784639295.USD","LU0577902454.USD","09115","02833","LU0164880469.USD","MCHmain","IE00B8HQ1Z84.USD","LU0107464264.USD","LU0117844026.USD","LU0039217434.USD","LU0054237671.USD","SG9999001689.USD","LU0856984785.SGD","LU1048596156.SGD","LU2237443895.HKD","LU0072462343.USD","BK4575","LU0348784397.USD","LU1051768304.USD","LU0314109678.HKD","LU0326950275.SGD","LU1956131251.USD","HK0000306685.HKD","LU2125910849.SGD","IE00B0169L03.USD","SG9999004220.SGD","LU2362540622.SGD","03419","IE0003895053.USD","LU0791591158.USD","LU1733274390.USD","LU1105468828.SGD","03033","LU1044874839.SGD","LU1868837565.USD","LU0543330566.HKD","IE0003851619.USD","LU1328615791.USD","LU0320764755.SGD","LU2265009873.SGD","LU1366334651.USD","BK4524","IE00BFMHRM44.USD","LU1064131003.USD","LU0345775950.USD","LU2498475776.HKD","BK4531","IE0032834883.USD","LU0052756011.USD","LU0516422440.USD","LU0588545904.SGD","LU0067412154.USD","LU0128522157.USD","07552","IE00BZ08YR35.GBP","LU1804176565.USD","LU0708995153.HKD","LU2293587155.HKD","BK1576","LU1720050803.USD","LU1282649067.USD","BK1604","BK1608","LU0651946864.USD","LU0244354667.USD","LU0577902298.EUR","LU1831875114.USD","LU0315179316.USD","LU0828237510.HKD","LU0873338254.USD","LU1282651048.USD","LU0048388663.USD","LU0348805143.USD","HK0000352382.USD","LU2257852520.SGD","LU2294711473.HKD","BK1526","LU0149534421.HKD","LU1196710864.SGD","BK1516","LU1235294995.USD","LU1883866441.USD","LU0502904849.HKD","IE0034224299.USD","LU0326948709.USD","HK0000320264.USD","SG9999017495.SGD","LU0289960550.SGD","LU0516423174.USD","LU0823041008.USD","LU0501845795.SGD","GB00BDT5M118.USD","BABO","LU1316542783.SGD","BK0012","MHImain","LU0173614495.USD","BK1095","LU0672654166.SGD","LU0708995583.HKD","LU0823397103.USD","LU1152091754.HKD","LU1226288253.USD","LU1629966141.USD","LU0359201885.HKD","LU0203347892.USD","LU2097828474.EUR","LU2362541273.HKD","IE00BZ08YS42.EUR","BK1517","LU0348788117.USD","LU0175139822.USD","HSImain","BABA","LU1044876610.USD","IE00B067MR52.USD","LU0384037296.USD","09088","SG9999013353.USD","LU1725190679.HKD","LU0293314216.USD","LU0588546209.SGD","LU2778985437.USD","89618","LU2097828631.EUR","LU0828238088.HKD","LU1102505762.USD","HSTECH","LU0589944569.HKD","LU0307460666.USD","BK1531","LU0128525689.USD","LU0210527791.USD","LU0821914370.USD","LU1046422090.SGD","LU0898667661.SGD","SG9999014906.USD","LU0192582467.USD","03115","LU1997245177.USD","LU0315178854.USD","LU0572939691.SGD","IE00B543WZ88.USD","LU0165289439.USD","LU0405327148.USD","LU1282651121.HKD","LU1048484197.HKD","BK1521","LU0096374516.USD","LU1188198961.HKD","LU2251237306.USD","LU0543330483.HKD","LU1255011170.USD","LU1688375341.USD","02837","LU2023250504.SGD","LU0588545490.SGD","LU0251144936.SGD","HSI","09067","LU2008162690.USD","SG9999000418.SGD","LU0211331839.USD","LU0791590937.USD","LU0070217475.USD","LU0797268264.HKD","LU1048588211.SGD","LU1770036033.HKD","SG9999002562.SGD","LU0405327494.USD","MHImain","BK4543","LU0862451837.USD","SG9999000459.SGD","LU0210533765.USD","LU0531970944.HKD","LU0329678170.USD","LU1282649810.SGD","KBAB","WXXWY","LU2237443382.USD","LU1868838027.USD","LU1868837722.USD","IE0008368411.USD","LU0348783662.USD","BK4554","LU0348825331.USD","LU0488056044.USD","LU0786609619.USD","LU0231483743.USD","LU0469268626.HKD","LU0048597586.USD","BK4585","IE0008369823.USD","LU0594300419.USD","LU2125910500.SGD","BK4581","LU1810669033.SGD","BK1141","IE00B3M56506.USD","LU0345769631.USD","LU0880133367.SGD","LU2488822045.USD","LU0862451753.SGD","HMTD.SI","BK4220","IE00BQXX3D17.EUR","LU1769817179.HKD","LU0738912210.USD","BK1591","BK4614","LU0611395673.USD","LU1961090484.USD","SG9999003461.SGD","LU0417516738.SGD","LU2152927971.USD","LU0269904917.USD","LU0431992006.USD","LU0359201612.USD","LU1224709979.USD","LU2279701549.SGD","LU1820825898.SGD","SG9999006597.SGD","LU2251237488.HKD","LU0633140560.USD","IE00B031J352.USD","HK0000914686.HKD","LU0561508036.HKD","BK0196","LU0738911758.USD","LU1807302812.USD","LU2148611432.USD","BK1233","BK4588","LU1568876251.USD","IE00B031HY20.USD","LU0348827113.USD","LU0029875118.USD","IE00B8L5B284.USD","LU0886674414.USD","LU1794554557.SGD","LU2237443978.SGD","LU1115378108.SGD","LU1003077747.HKD","IE00B0JY6N72.USD","LU0140636845.USD","BK0183","HK0000306701.USD","SG9999015986.USD","LU2399975544.HKD","LU0011963245.USD","BK0060","LU0048580855.USD","BK1615","LU2495084118.USD","SGXZ51526630.SGD","SGXZ90724238.SGD","LU0164865239.USD","SG9999001051.SGD","LU1023057109.AUD","LU1226288097.SGD","SG9999007991.SGD","LU0675040207.SGD","LU2051468812.USD","LU0499858602.USD","LU0348816934.USD","LU1303224171.USD","LU0072913022.USD","LU0345776255.USD","LU0819121731.USD","LU0979878070.USD","01276","LU0051755006.USD","LU0417516902.SGD","LU0831103253.SGD","LU0700851271.USD","LU0456846285.SGD","LU1366334578.USD","LU0210526637.USD","LU0661504455.SGD","LU1226287529.USD","LU0441854154.USD","BK4526","LU1981816686.USD","LU2476274720.SGD","LU1951186391.HKD","LU0540923850.HKD","LU1211504680.USD","LU1224444064.USD","LU0949170772.SGD","LU1997245094.SGD","LU0634319403.HKD","IE00B031HW06.USD","LU0823426308.USD","LU0214875030.USD","LU2097828714.EUR","LU0531971595.HKD","BK1586","SG9999014914.USD","LU0117841782.USD","LU0143863198.USD","IE00BZ08YT58.USD","SG9999001093.SGD","LU0047713382.USD","IE0031814852.USD","LU2289578879.USD","SG9999018865.SGD","LU2247934214.USD","HK0000352291.HKD","LU0456842615.SGD","LU1323998911.USD","07500","LU0651947912.USD","BK4527","BABU","BK0188","BK4533","LU0054450605.USD","LU0163747925.USD","SG9999014898.SGD","LU0287142896.SGD","LU0211977185.USD","SG9999014880.SGD","BK4579","LU1655091459.SGD","LU1515016050.SGD","LU0878004406.USD","LU1196710195.USD","IE0001KFT4U8.USD","LU1785774172.SGD","SG9999006514.SGD","LU0577902611.USD","LU2462611646.USD","LU1051769294.HKD","LU2476274308.USD","LU0080751232.USD","LU1251922891.USD","LU1770034418.SGD","LU0545039389.USD","LU0828237940.HKD","LU0823413587.USD","LU0588545730.USD","LU2045819591.USD","LU1267930227.SGD","LU0348814723.USD","LU2039709279.SGD","LU1580142542.USD","LU0359202008.SGD","LU0228367735.SGD","LU0320764599.SGD","LU0320764243.SGD","BK4548","SG9999001846.SGD","LU2242644610.SGD","LU0348783233.USD","LU0890818403.SGD","LU0648948544.HKD","07226","LU0348723411.USD","BK1618","LU1196710351.USD","LU1282649141.HKD","LU0329678337.USD","LU0871576103.HKD","SG9999001903.USD","LU0823040885.USD","HK0000914660.USD","LU0181495838.USD","IE00BQXX3F31.USD","LU2362541513.USD","03417","LU0310800965.SGD","LU0737861772.HKD","LU1046421795.USD","LU0251143458.SGD","LU0650527681.SGD","LU0823413660.USD","LU1235295612.USD","SGXZ99366536.SGD","03690","SG9999015978.USD","83115","LU0228659784.USD","LU1655091616.SGD","LU0463099449.HKD","IE0032431581.USD","BABX","BBYY","LU0049853897.USD","LU0605514214.HKD","IE00B29SXG58.USD","LU0043850808.USD","LU0541501648.USD","LU0516422952.EUR","BK1249","IE00B97KM107.HKD","LU1781817850.SGD","HK0000320223.HKD","LU0188438112.USD","BK4503","LU1691799644.USD","LU0106252389.USD","82800","LU1504937902.USD","LU0169518387.USD","LU2237443465.HKD","LU0449515922.USD","SG9999015945.SGD","LU1282648689.USD","LU0607220059.USD","LU1808992512.USD","LU1813983027.USD","LU0235996351.USD","LU0608807946.USD","HK0000151867.HKD","LU1718418525.SGD","LU1734074674.USD","BK4502"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120833192","title":"Hengrui Pharma Reports Cumulative Share Buyback of 12.06 Million A-Shares by End of May","url":"https://stock-news.laohu8.com/highlight/detail?id=1120833192","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120833192?lang=en_us&edition=fundamental","pubTime":"2026-06-02 17:18","pubTimestamp":1780391901,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) has issued an announcement regarding its share repurchase activities.In May 2026, the company did not repurchase any shares through the block trading system of the Shanghai...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","LU2097828557.USD","BK0028","LU1655091616.SGD","LU1781817850.SGD","LU0405327148.USD","BK0060","LU1820825898.SGD","LU2148510915.USD","BK0239","LU1969619763.USD","LU0359201612.USD","LU1997244956.HKD","LU1328615791.USD","BK0183","399300","BK1191","LU0359201885.HKD","LU1255011170.USD","600276","LU1997245094.SGD","LU1580142542.USD","LU2097828805.USD","LU2543165471.USD","LU1997245177.USD","LU2495084118.USD","LU0405327494.USD","LU2580892862.HKD","159982","LU1064130708.USD","BK0196","LU0359202008.SGD","LU2097828474.EUR","LU2289578879.USD","LU2097828714.EUR","LU2488822045.USD","BK0012","LU2580892789.USD","LU1146622755.USD","LU1064131003.USD","01276","LU2097828631.EUR","LU1023057109.AUD","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130414847","title":"HENGRUI PHARMA Reports 2025 Revenue of 31.63 Billion Yuan, Up 13.02% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1130414847","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130414847?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:20","pubTimestamp":1780060849,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA stated that while secondary market fluctuations are influenced by multiple factors, the company's operational performance continues to improve steadily, with an overall positive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1146622755.USD","BK0060","LU1997245177.USD","600276","LU1255011170.USD","LU2495084118.USD","LU0359201612.USD","LU1023057109.AUD","LU1328615791.USD","LU1997245094.SGD","LU0405327494.USD","LU0359201885.HKD","LU1064130708.USD","BK0012","BK0188","BK1191","LU2097828557.USD","LU2328871848.SGD","LU2543165471.USD","LU0359202008.SGD","LU2148510915.USD","LU2580892862.HKD","BK0183","BK0239","BK0028","LU2488822045.USD","LU2097828805.USD","LU2097828714.EUR","LU2580892789.USD","LU1655091616.SGD","BK0196","LU2289578879.USD","01276","LU0405327148.USD","LU1580142542.USD","LU1064131003.USD","LU2097828631.EUR","LU1997244956.HKD","LU1820825898.SGD","LU1781817850.SGD","LU2097828474.EUR","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639064639","title":"DIARY-China corporate earnings week ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2639064639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639064639?lang=en_us&edition=fundamental","pubTime":"2026-05-29 12:00","pubTimestamp":1780027200,"startTime":"0","endTime":"0","summary":"DIARY-China corporate earnings week aheadMay 29 (Reuters) - Diary of China (.CSI300) corporate earnings for the week ahead.CHINA EARNINGS Start DateStart Time(GMT)RICCompany NameEvent Name01-Jun-20260","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4N4251NE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601877","LU2289578879.USD","605117","BK0082","BK0201","LU2580892862.HKD","600674","LU1328615791.USD","BK0006","LU1146622755.USD","LU1580142542.USD","LU2580892789.USD","BK0168","LU1997245177.USD","LU1969619763.USD","BK0060","BK0239","BK0196","LU2495084118.USD","SGXZ49509284.SGD","BK0217","BK4563","LU2328871848.SGD","BK0028","LU2097828631.EUR","600150","SGXZ81163826.USD","LU1997245094.SGD","LU1255011170.USD","LU1781817850.SGD","LU2097828805.USD","LU1064130708.USD","BK0054","RES","BK0000","601360","BK0076","BK0024","LU2488822045.USD","BK0078","600161","BK0020","600276","LU2148510915.USD","601689","BK0271","BK0185","LU2097828714.EUR","BK0012","BK0224"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145355528","title":"HENGRUI PHARMA's Novel Drug SHR4640 Tablets Receive Marketing Authorization","url":"https://stock-news.laohu8.com/highlight/detail?id=1145355528","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145355528?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:54","pubTimestamp":1779976499,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA announced that its wholly-owned subsidiary, Jiangsu Hengrui Pharmaceuticals Co., Ltd., has received notification from the National Medical Products Administration approving the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","LU2097828557.USD","BK0028","LU1655091616.SGD","LU1781817850.SGD","LU0405327148.USD","BK0060","LU1820825898.SGD","LU2148510915.USD","BK0239","LU1969619763.USD","LU0359201612.USD","LU1997244956.HKD","LU1328615791.USD","BK0183","BK1191","LU0359201885.HKD","LU1255011170.USD","600276","LU1997245094.SGD","LU1580142542.USD","LU2097828805.USD","LU2543165471.USD","LU1997245177.USD","LU2495084118.USD","LU0405327494.USD","LU2580892862.HKD","LU1064130708.USD","LU2289578879.USD","BK0196","LU0359202008.SGD","LU2097828474.EUR","LU2097828714.EUR","LU2488822045.USD","BK0012","LU2580892789.USD","LU1146622755.USD","LU1064131003.USD","01276","LU2097828631.EUR","LU1023057109.AUD","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638699912","title":"Jiangsu Hengrui Pharmaceuticals -  Received Nmpa Notice Approving Class 1 Innovative Drug Ruzinurad Tablets (Shr4640 Tablets) for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2638699912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638699912?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:49","pubTimestamp":1779976164,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nFWN425115:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","LU0359202008.SGD","LU1146622755.USD","LU2097828805.USD","LU1580142542.USD","LU2097828557.USD","LU1997245094.SGD","LU1328615791.USD","LU0359201885.HKD","600276","LU2580892789.USD","LU0405327494.USD","LU2488822045.USD","BK0028","LU2097828474.EUR","LU1781817850.SGD","BK0183","BK0188","BK0196","LU0359201612.USD","LU1064131003.USD","LU1997245177.USD","BK0060","LU1969619763.USD","LU2328871848.SGD","LU1820825898.SGD","LU2289578879.USD","LU2495084118.USD","LU1997244956.HKD","BK0012","LU1023057109.AUD","LU2543165471.USD","01276","BK1191","LU1255011170.USD","LU2097828631.EUR","LU2097828714.EUR","LU0405327148.USD","LU1655091616.SGD","LU1064130708.USD","LU2580892862.HKD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166619871","title":"HENGRUI PHARMA's Subsidiary Receives Clinical Trial Approval for SHR-1819 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1166619871","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166619871?lang=en_us&edition=fundamental","pubTime":"2026-05-28 17:08","pubTimestamp":1779959310,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (600276.SH) announced that its subsidiary, Guangdong Hengrui Pharmaceutical Co., Ltd., recently received a \"Drug Clinical Trial Approval Notice\" for the SHR-1819 injection from the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","LU2580892789.USD","LU1146622755.USD","LU2097828631.EUR","LU1023057109.AUD","LU0359201885.HKD","LU1997245177.USD","LU0405327494.USD","BK0239","LU2097828714.EUR","LU2289578879.USD","01276","LU1064131003.USD","LU2488822045.USD","LU2148510915.USD","LU1255011170.USD","LU2097828805.USD","LU1997244956.HKD","LU1820825898.SGD","BK0183","LU1997245094.SGD","BK0196","BK0188","LU2328871848.SGD","LU2580892862.HKD","LU2097828557.USD","LU1064130708.USD","LU1781817850.SGD","LU1580142542.USD","BK0060","BK0028","LU0359201612.USD","LU1969619763.USD","LU2495084118.USD","LU1655091616.SGD","LU1328615791.USD","LU2097828474.EUR","LU0359202008.SGD","LU2543165471.USD","BK1191","LU0405327148.USD","600276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638966615","title":"Jiangsu Hengrui Pharmaceuticals  Says Shr4640 Approved by China's Medical Products Administration for Treating Patients With Gout and Hyperuricemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2638966615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638966615?lang=en_us&edition=fundamental","pubTime":"2026-05-28 17:00","pubTimestamp":1779958822,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nL4N4250RD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","BK0196","LU2580892789.USD","LU2289578879.USD","LU1580142542.USD","LU2097828631.EUR","LU1655091616.SGD","LU1146622755.USD","LU2580892862.HKD","BK0188","LU2097828805.USD","LU0405327494.USD","LU1969619763.USD","BK0012","LU1997245177.USD","BK0183","LU1997244956.HKD","BK0060","LU1064130708.USD","LU2328871848.SGD","LU1781817850.SGD","LU2495084118.USD","LU0405327148.USD","LU1997245094.SGD","LU1328615791.USD","BK0028","600276","LU2097828474.EUR","LU1064131003.USD","LU2097828557.USD","LU1820825898.SGD","LU2148510915.USD","BK0239","LU2097828714.EUR","LU1255011170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181654185","title":"Pharmaceutical Sector Shows Resilience at Low Levels, Huabao Pharma ETF (562050) Rises Against Market Trend in Afternoon Session! Leading Stock Hengrui Pharma Surges 4%, Traditional Chinese Medicine Leaders All in the Green","url":"https://stock-news.laohu8.com/highlight/detail?id=1181654185","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181654185?lang=en_us&edition=fundamental","pubTime":"2026-05-27 14:31","pubTimestamp":1779863483,"startTime":"0","endTime":"0","summary":"On the afternoon of May 27, the A-share market experienced a sudden downturn, with the Shanghai Composite Index falling below 4100 points. The pharmaceutical sector showed localized activity, with...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201885.HKD","LU1328615791.USD","LU2148510915.USD","BK1191","LU2097828714.EUR","LU1146622755.USD","LU2097828631.EUR","LU0359202008.SGD","LU2097828474.EUR","BK4588","BK0028","LU1023057109.AUD","LU2328871848.SGD","01477","LU2488822045.USD","LU1255011170.USD","LU2580892862.HKD","LU1820825898.SGD","LU0359201612.USD","BK0239","LU1655091616.SGD","LU2097828805.USD","BK0196","01276","LU2495084118.USD","LU2543165471.USD","600276","LU1064131003.USD","LU1969619763.USD","BK0188","LU0405327494.USD","BK4585","LU2097828557.USD","BK0060","LU0405327148.USD","LU1997245094.SGD","FDN","LU1781817850.SGD","LU1580142542.USD","LU1997245177.USD","BK4550","562050","LU2289578879.USD","LU2580892789.USD","LU1064130708.USD","LU1997244956.HKD","BK0012","BK1574","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122795185","title":"HENGRUI PHARMA Subsidiary Receives NMPA Approval for HRS-1635 Tablets Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1122795185","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122795185?lang=en_us&edition=fundamental","pubTime":"2026-05-26 16:54","pubTimestamp":1779785665,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (600276.SH) announced that its subsidiary, Chengdu Shengdi Pharmaceutical Co., Ltd., has recently received a Drug Clinical Trial Approval Notice for HRS-1635 tablets from the National...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU1255011170.USD","BK0188","BK0196","LU1580142542.USD","LU2097828557.USD","BK0028","LU1064131003.USD","LU2543165471.USD","LU0359201612.USD","LU2580892862.HKD","LU1997244956.HKD","600276","LU1997245094.SGD","LU1146622755.USD","BK1191","LU1781817850.SGD","LU1655091616.SGD","LU2097828805.USD","LU2148510915.USD","LU1328615791.USD","LU0359202008.SGD","LU1064130708.USD","LU1023057109.AUD","BK0060","LU0405327494.USD","BK0012","LU2097828631.EUR","LU1997245177.USD","LU0359201885.HKD","LU2580892789.USD","01276","BK0239","LU2097828714.EUR","LU2289578879.USD","LU1820825898.SGD","LU2328871848.SGD","BK0183","LU0405327148.USD","LU2495084118.USD","LU2488822045.USD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636989151","title":"Hengrui Pharma Gets China Regulatory Nod for Catabolic Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2636989151","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636989151?lang=en_us&edition=fundamental","pubTime":"2026-05-20 10:14","pubTimestamp":1779243285,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  obtained approval from China's National Medical Products Administration to market a nutritional injection for adult patients in catabolic states, according to a Shanghai bourse filing on Wednesday.The regulatory nod clears the drugmaker to commercialize its omega-3 triglyceride (2%) medium/long chain fat emulsion/amino acid /glucose (30%) injection, which supplies essential parenteral energy and nutrients to patients experiencing moderate to severe catabolism.The company has so far invested 83.9 million yuan into the research and development of the treatment.The pharmaceutical company's shares fell 1% during morning trade on Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2580892862.HKD","LU2097828714.EUR","LU2328871848.SGD","LU1997245177.USD","LU0405327148.USD","LU1064131003.USD","BK0239","BK0060","BK0183","LU1328615791.USD","LU1064130708.USD","LU2097828474.EUR","BK0188","LU2580892789.USD","BK0028","BK0012","LU1997245094.SGD","LU1146622755.USD","LU1997244956.HKD","LU2148510915.USD","600276","LU0405327494.USD","LU2097828805.USD","LU1580142542.USD","LU2495084118.USD","LU1781817850.SGD","LU1255011170.USD","LU2488822045.USD","LU2097828631.EUR","BK0196","LU2289578879.USD","LU1655091616.SGD","LU1820825898.SGD","LU1969619763.USD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115310030","title":"HENGRUI PHARMA's ω-3 Triglyceride (2%) MCT/LCT Fat Emulsion/Amino Acids (16)/Glucose (30%) Receives Drug Registration Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1115310030","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115310030?lang=en_us&edition=fundamental","pubTime":"2026-05-19 18:24","pubTimestamp":1779186277,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA announced that its subsidiary, Fujian Shengdi Pharmaceutical Co., Ltd., has received notification from the National Medical Products Administration that the ω-3 Triglyceride (2%)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1255011170.USD","LU2488822045.USD","BK0196","LU2580892789.USD","LU2289578879.USD","LU2543165471.USD","01276","LU1580142542.USD","LU0359202008.SGD","LU2097828631.EUR","LU1655091616.SGD","LU1146622755.USD","LU2580892862.HKD","BK0188","LU2097828805.USD","LU0405327494.USD","LU1969619763.USD","BK0012","LU1997245177.USD","BK0183","LU1997244956.HKD","BK0060","LU1064130708.USD","LU2328871848.SGD","LU1781817850.SGD","LU2495084118.USD","LU0405327148.USD","LU0359201612.USD","LU1997245094.SGD","LU1328615791.USD","LU1023057109.AUD","600276","LU0359201885.HKD","LU2097828474.EUR","BK1191","LU1064131003.USD","LU2097828557.USD","LU1820825898.SGD","LU2148510915.USD","BK0239","LU2097828714.EUR","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130072639","title":"Schroders PLC Increases Stake in Hengrui Pharma by 663,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1130072639","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130072639?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:58","pubTimestamp":1779105507,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on May 12, Schroders PLC increased its holding in HENGRUI PHARMA (01276) by 663,000 shares. The transaction was executed at a price of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","LU2097828474.EUR","LU1997244956.HKD","LU1064130708.USD","BK0183","LU2495084118.USD","LU1255011170.USD","BK0028","LU2097828805.USD","LU0405327148.USD","BK0012","LU0405327494.USD","LU1146622755.USD","LU1820825898.SGD","LU2580892862.HKD","LU1997245177.USD","LU2543165471.USD","LU2289578879.USD","BK0188","EWH","LU1969619763.USD","LU2097828631.EUR","LU2148510915.USD","LU0359201612.USD","LU1655091616.SGD","LU2097828557.USD","LU2328871848.SGD","01276","LU1064131003.USD","LU1580142542.USD","BK0060","600276","LU0359202008.SGD","LU1328615791.USD","BK1191","LU1781817850.SGD","LU1997245094.SGD","LU2097828714.EUR","LU2580892789.USD","LU2488822045.USD","LU1023057109.AUD","LU0359201885.HKD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635882430","title":"Hengrui Pharmaceuticals' Development Capabilities Undervalued -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635882430","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635882430?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:09","pubTimestamp":1778839740,"startTime":"0","endTime":"0","summary":"1009 GMT - Hengrui Pharmaceuticals' research and development and business development capabilities remain undervalued, HSBC researchers say in a note. They highlight the value of Hengrui's recent $15.2 billion deal with Bristol Myer-Squibb exceeded its deal with GSK last year, reflecting broad recognition of Hengrui's R&D capabilities and efficiency. The drugmaker's strong clinical pipeline and efficient drug discovery platform should support a recurring business development model and create additional collaboration opportunities. HSBC maintains its 2026 results forecasts but raises its 2027-2028 revenue and net profit estimates as well as its R&D costs projections. Industry-wise, Chinese drugmakers are likely to continue securing business development deals with multinational pharmaceutical companies despite geopolitical risks, supported by high efficiency, lower R&D costs and improving data transparency. Hengrui's H-shares last closed at HK$65.75. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1655091616.SGD","LU2097828557.USD","LU0405327494.USD","BK0188","LU2580892789.USD","HSBH","BK0060","LU1997244956.HKD","LU2580892862.HKD","BK0183","LU0128525689.USD","LU1064130708.USD","LU1781817850.SGD","LU1820825898.SGD","BK0239","LU2148510915.USD","LU2097828714.EUR","BK0196","LU0976567544.SGD","LU0405327148.USD","LU1328615791.USD","LU1580142542.USD","600276","LU0211326755.USD","LU1255011170.USD","LU1146622755.USD","LU2097828631.EUR","LU2488822045.USD","LU2097828805.USD","LU2495084118.USD","LU0052756011.USD","BK4521","LU1969619763.USD","LU2236285917.USD","LU1267930227.SGD","LU0496365809.HKD","LU1064131003.USD","BK4207","BK0028","LU1997245177.USD","BK4585","LU2289578879.USD","LU0310800965.SGD","BK4588","LU2328871848.SGD","LU0211326839.USD","LU1997245094.SGD","HSBC","LU2097828474.EUR","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137880618","title":"HENGRUI PHARMA's Subsidiary Gains Approval for Clinical Trials of SHR-3079 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1137880618","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137880618?lang=en_us&edition=fundamental","pubTime":"2026-05-14 16:48","pubTimestamp":1778748516,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA announced that its subsidiary, Suzhou Shengdiya Biopharmaceutical Co., Ltd., recently received a \"Drug Clinical Trial Approval Notice\" for SHR-3079 injection from the National Medical...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0239","LU1580142542.USD","LU2148510915.USD","LU1328615791.USD","BK0183","LU1781817850.SGD","BK0012","LU1997245094.SGD","LU2580892789.USD","LU1023057109.AUD","LU1064130708.USD","BK0188","LU2097828805.USD","LU2289578879.USD","01276","LU0359201885.HKD","LU2543165471.USD","LU1146622755.USD","LU0359202008.SGD","LU1820825898.SGD","LU2097828714.EUR","BK0028","LU0405327148.USD","LU2495084118.USD","LU1255011170.USD","LU1969619763.USD","BK0196","LU2328871848.SGD","LU1064131003.USD","LU2580892862.HKD","BK1191","LU2097828557.USD","LU2097828631.EUR","LU0405327494.USD","LU1997244956.HKD","LU2488822045.USD","LU2097828474.EUR","LU0359201612.USD","600276","LU1655091616.SGD","LU1997245177.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100038164","title":"Morgan Stanley: Hengrui Pharma's $15.2 Billion Partnership with BMS to Accelerate Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1100038164","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100038164?lang=en_us&edition=fundamental","pubTime":"2026-05-13 11:00","pubTimestamp":1778641225,"startTime":"0","endTime":"0","summary":"Morgan Stanley has issued a research report highlighting a global strategic collaboration between Hengrui Pharma and Bristol Myers Squibb, covering 13 pre-clinical assets with a total transaction...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d8fdac8d3d9097cb034fb43ab6bd5883","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1146622755.USD","LU0405327494.USD","BK0239","BK0060","BK0188","LU1969619763.USD","LU1580142542.USD","BK0028","600276","LU1064130708.USD","LU2097828474.EUR","LU1255011170.USD","BK0012","LU2148510915.USD","LU0359202008.SGD","LU2328871848.SGD","LU1997245094.SGD","BK1191","LU1655091616.SGD","LU2097828557.USD","BMS","LU2097828714.EUR","LU1997244956.HKD","LU2097828631.EUR","01276","LU1781817850.SGD","LU1820825898.SGD","LU1997245177.USD","LU2097828805.USD","LU2289578879.USD","LU1023057109.AUD","BK0183","LU2495084118.USD","LU1328615791.USD","LU2488822045.USD","LU2580892789.USD","LU0359201612.USD","LU0359201885.HKD","LU2543165471.USD","LU0405327148.USD","LU2580892862.HKD","LU1064131003.USD","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634121464","title":"Dow Jones Top Company Headlines at 9 AM ET: EBay Rejects GameStop's $56 Billion Takeover Proposal | Under ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2634121464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634121464?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:00","pubTimestamp":1778590800,"startTime":"0","endTime":"0","summary":"The e-commerce platform called the offer \"neither credible nor attractive\" after a rollout by GameStop CEO Ryan Cohen appeared to fizzle.Under Armour reported a fiscal fourth-quarter loss as revenue declines in North America offset international sales gains.JD.com returned to profit with better-than-expected results in the first quarter, as the Chinese e-commerce giant made progress in stemming losses in its food-delivery business.Bristol-Myers Squibb and China's Hengrui Pharma Forge Tie-Up. U.S. pharma giant Bristol-Myers Squibb has struck a partnership and licensing deal with Chinese drugmaker Hengrui, in a deal that could worth more than $15 billion.EU's Von der Leyen Floats Tighter Restrictions for Minors' Social Media Use. The European Union could present new rules to tighten restrictions on minors' use of social media platforms this summer.Nvidia Stock Drops After Report CEO Huang Is Excluded From Trump's China Trip. Sam Altman's Business Dealings Under GOP Scrutiny Ahead of Open","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"c1ee3020066801ecc9807d71c3848eaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276","BK4577","NVDA","UAA","BK4581","GME","BK4144","ADNOC.AU","EBAY","IGME","BK4547","TCEHY","IE00BZ18W456.USD","IE00BMQBXF63.USD","01024","BK4585","JD","BK4590","BK4076","600276","09618","GMEU","BMY","00700","IE00BZ18W340.USD","BK4588","NVO","RGTI","DJIA","GMEY","BZFD","BAYRY","BK4561"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2000-10-18","address":"江苏省连云港市连云区经济技术开发区黄河路38号","stockEarnings":[{"period":"1week","weight":-0.062},{"period":"1month","weight":-0.1185},{"period":"3month","weight":-0.1492},{"period":"6month","weight":-0.2328},{"period":"1year","weight":-0.1226},{"period":"ytd","weight":-0.2064}],"companyName":"江苏恒瑞医药股份有限公司","boardCode":"AI0027","perCapita":"13918股","boardName":"医药制造业","registeredCapital":"663719万元","compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0318},{"period":"3month","weight":-0.0234},{"period":"6month","weight":0.032},{"period":"1year","weight":0.1902},{"period":"ytd","weight":0.0148}],"survey":"　　江苏恒瑞医药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是马来酸吡咯替尼片、注射用卡瑞利珠单抗、瑞维鲁胺片、海曲泊帕乙醇酰胺片、羟乙磺酸达尔西利片、碘佛醇注射液。自2019年起，公司连续七年跻身美国《制药经理人》(PharmExec)杂志评选的全球制药企业50强榜单。","serverTime":1780781483036,"listedPrice":11.98,"stockholders":"458309人(较上一季度增加1.93%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.,600276,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票老虎,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票老虎国际,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.行情,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票行情,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股价,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股市,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票价格,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票交易,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票购买,Jiangsu Hengrui Pharmaceuticals Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jiangsu Hengrui Pharmaceuticals Co.,Ltd.(600276) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction